RNS - earnings-enhancing acquisition4 Apr 2025 08:51
A nice bolt-on acquisition today, earnings-enhancing in the coming year. The acquisition multiple looks good value at slightly less than their usual multiples paid, and there's plenty of room for synergies and savings:
Https://uk.advfn.com/stock-market/london/sdi-SDI/share-news/SDI-Group-PLC-Acquisition-of-Collins-Walker/95784981
Today's news implies confidence going forward, bolstered by Ken Ford's recent share buying and the previous in-line guidance.
Cavendish this morning have left their forecast for the year ending this month at 6.2p EPS, but have raised their forecast for the year starting 1st May slightly to 6.9p EPS.
They reiterate their 135p target price, and summarise:
"Valuation:
We maintain our existing 135p target price, based on a FY26E P/E of 19.6x. This offers significant upside to current levels, with the shares trading on an attractive FY26E P/E of 7.1x. This remains a significant discount to its nearest peer Judges Scientific (trading on FY2 P/E of 18.7x). We feel the group’s value should be inherently greater than its acquisition multiples (as we have mentioned, the average acquisition EBIT multiple is 6.4x), particularly as management is now focusing on generating operational efficiencies and integration synergies between its existing group subsidiaries."